These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative activity of ceftizoxime and four other cephalosporins against gram negative bacteria and their sensitivity to beta-lactamases. Esposito S, Galante D, Barba D, Pennucci C, Limauro D. Microbiologica; 1985 Apr; 8(2):197-204. PubMed ID: 3874342 [Abstract] [Full Text] [Related]
3. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)]. Nasnas R, Gutmann L, Kitzis MD, Goldstein F, Acar JF. Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385 [Abstract] [Full Text] [Related]
7. In vitro antibacterial activity of ceftizoxime against gram-negative strains. Debbia E, Soro O. Chemioterapia; 1985 Apr; 4(2):166-9. PubMed ID: 3891115 [Abstract] [Full Text] [Related]
10. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases. Raimondi A, Mattina R, Cocuzza CE. Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365 [Abstract] [Full Text] [Related]
12. In vitro susceptibility tests with cefoperazone compared with cefotaxime, cefoxitin, cefuroxime, cephaloridine and gentamicin. Brenciaglia MI, Cipriani P, Ghezzi MC, Giordano A, Mancini C, Rivanera D, Filadoro F. Chemioterapia; 1984 Aug; 3(4):246-9. PubMed ID: 6099754 [Abstract] [Full Text] [Related]
13. Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents. Bell JM, Turnidge JD, Cefepime Study Group. Pathology; 2001 Feb; 33(1):53-60. PubMed ID: 11280610 [Abstract] [Full Text] [Related]
15. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime]. Rouhan D, Le Noc P, Le Noc D. Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713 [Abstract] [Full Text] [Related]
16. In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens. Vouillamoz J, Moreillon P, Giddey M, Entenza JM. J Antimicrob Chemother; 2008 Feb; 61(2):371-4. PubMed ID: 18033780 [Abstract] [Full Text] [Related]